Aumet, the Saudi Arabia-based AI-driven procurement platform for healthcare, has secured $12 million in Series A funding, marking a pivotal moment for the kingdom’s ambition to establish itself as a global technology hub. The funding round, led by Riyadh-based Emkan Capital with participation from Qatar Development Bank, SABAH VC, AAIC, Shorooq Partners, and Right Side Capital Management, underscores the growing sophistication of the MENA region’s venture capital ecosystem while signaling increased sovereign investor interest in healthtech infrastructure. This capital injection positions Aumet to accelerate its expansion across the GCC and beyond, reflecting the broader strategic shift toward digital transformation in one of the world’s most digitally ambitious regions.
The involvement of Qatar Development Bank and other regional institutional investors highlights a significant trend of sovereign capital deployment into domestic technology sectors. Unlike traditional venture capital approaches that prioritize financial returns, these sovereign-backed funds are increasingly focused on building long-term regional competitiveness and reducing dependency on external technology providers. Emkan Capital’s participation as both lead investor and strategic partner further demonstrates the GCC’s evolution toward more coordinated investment strategies, where venture capital firms serve as conduits for broader economic development objectives. This dynamic reflects Saudi Arabia’s Vision 2030 imperative to diversify its economy while leveraging technology to modernize critical infrastructure sectors.
From a regional infrastructure perspective, Aumet’s expansion represents more than corporate growth—it signals the maturation of MENA’s healthcare technology ecosystem. With current deployments across 12,000 pharmacies in Jordan, Egypt, and Saudi Arabia, and enterprise solutions serving dozens of hospitals through partnerships with Jordan’s Ministry of Health and Presight, the platform is already embedded in the region’s healthcare supply chain. The planned global rollout of its Pulse platform and expansion into new markets will create network effects that strengthen the entire regional healthcare technology stack. This development is particularly significant as governments across the MENA region continue to invest billions in healthcare digitization, creating substantial addressable markets for homegrown technology solutions.
The funding validates the broader thesis that MENA’s technology sector is transitioning from experimentation to scalable impact. Aumet’s AI-first approach to procurement—addressing critical pain points in inventory management and supply chain optimization—directly addresses inefficiencies that cost healthcare systems across the region billions annually. As sovereign wealth funds and development banks increasingly back enterprise technology with clear pathways to public sector adoption, companies like Aumet demonstrate how regional champions can achieve both commercial success and strategic national importance. This convergence of venture capital dynamics with sovereign economic objectives represents a defining characteristic of MENA’s technology investment landscape moving forward.
